Liraglutide should not be injected in people who do not have diabetes. Liraglutide belongs to the hypoglycemic drugs, mainly suitable for adults with type 2 diabetes mellitus to control blood sugar, can be combined with metformin or sulfonylurea drugs. It should not be used in patients without diabetes mellitus, hypoglycemic reactions may occur, with adverse consequences. The drug requires careful monitoring of blood glucose levels during application. Common adverse reactions include gastrointestinal disturbances such as vomiting, constipation, abdominal pain, dyspepsia, etc., as well as side effects such as hypoglycemic reactions, allergic reactions, etc. The drug is contraindicated in patients with type 1 diabetes mellitus, patients with diabetic ketoacidosis, patients with allergy to the active ingredient of the product, or to any of the other excipients in the product. It is recommended to use Liraglutide under the supervision of a doctor and not for private use.